Benczur M, Györffy G, Garam T, Varga M, Medgyesi G, Sándor M, Petranyi G G
Immunobiology. 1979 Sep;156(3):320-9.
Human sera enhanced spontaneous cell-mediated cytotoxicity (SCMC), while anti-IgG (Fab') 2 treatment decreased this cytotoxic activity of human lymphocytes for an in vitro growing cell line (K--562). Trypsin treatment of the effector cells considerably decreased the cytotoxic potential. However, a significant cytotoxic activity could always be found in serum-free medium. While these findings suggest the involvement of antibodies in the SCMC, they also reflect the existence of serum-indpendent (sui generis) SCMC activity of lymphocytes. Removal of SCMC of Fc receptor bearing effector cells was performed by target cell adherence (rosetting). Separation of the target cell-bound lymphocytes was done by centrifugation on special Ficoll gradient. The depletion of SCMC effector cells resulted in a 62% reduction of SCMC and in a 39% reduction of ADCC. On the other hand, removal of Fc bearing effector cells showed a similar reduction in both ADCC (66%) and SCMC (78%). Our results suggest that SCMC represents a complex activity, arising partly from the interactions of certain serum-derived or lymphocytes surface-bound antibodies and partly from a spontaneous cytotoxic function of the effector cells. It is possible that the effector cells involved in both SCMC and ADCC derive from the same lymphocyte population and the differences are due mainly to the lower number of SCMC effector cells.
人血清增强了自发细胞介导的细胞毒性(SCMC),而抗IgG(Fab')2处理降低了人淋巴细胞对体外生长细胞系(K-562)的这种细胞毒性活性。用胰蛋白酶处理效应细胞可显著降低其细胞毒性潜力。然而,在无血清培养基中总能发现显著的细胞毒性活性。虽然这些发现提示抗体参与了SCMC,但它们也反映了淋巴细胞存在不依赖血清(独特的)SCMC活性。通过靶细胞黏附(花环形成)去除带有Fc受体的效应细胞的SCMC。通过在特殊的Ficoll梯度上离心来分离与靶细胞结合的淋巴细胞。SCMC效应细胞的耗竭导致SCMC降低62%,ADCC降低39%。另一方面,去除带有Fc的效应细胞显示ADCC(66%)和SCMC(78%)均有类似程度的降低。我们的结果提示,SCMC代表一种复杂的活性,部分源于某些血清来源的或淋巴细胞表面结合的抗体之间的相互作用,部分源于效应细胞的自发细胞毒性功能。参与SCMC和ADCC的效应细胞可能来自同一淋巴细胞群体,差异主要是由于SCMC效应细胞数量较少。